指南与共识前列腺癌

机器人辅助根治性前列腺切除术中离体荧光共聚焦显微镜应用的Delphi共识

Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy.
指南 / 共识 · BJU Int · 2026-06-10

该国际Delphi共识采用RAND/UCLA适宜性方法和ACCORD清单,由32名泌尿外科与病理学专家对44项循证条目进行匿名投票,共识阈值≥80%。24项条目达成共识,涵盖风险适配使用FCM、辅助MRI决策神经保留、en-face成像为首选技术、最长报告时间30分钟等推荐。

要点

  • FCM风险适配使用(97%)及作为MRI辅助神经保留决策(87%)达成共识。
  • en-face成像为优选FCM技术(82%),最长报告时间30分钟(85%)。
  • 高危病例>3 mm阳性切缘需完全切除神经血管束(96%)。

核心结论

  • 共识为RARP术中FCM使用提供结构化框架,明确适应证、工作流程标准和培训要求。
  • 未来需多中心研究评估FCM的肿瘤学与功能学影响并建立标准化实施路径。

研究设计与样本

  • 改良Delphi流程遵循RAND/UCLA适宜性方法并按ACCORD清单报告。
  • 32名国际泌尿外科与病理学专家参与混合共识会议,基于结构化文献回顾和预备在线会议。
  • 制定44项循证多选题条目,涵盖患者选择、图像采集和手术管理领域,通过安全在线平台匿名投票。
  • 共识预定义为受访者≥80%一致。

主要发现

  • 44项条目中24项(55%)达成共识。
  • 风险适配使用FCM达成97%共识。
  • FCM作为MRI辅助用于神经保留决策达成87%共识。
  • en-face成像作为首选FCM技术达成82%共识。
  • 最长报告时间30分钟达成85%共识。

关键数值与推荐

  • 图像解读正式认证达成83%共识。
  • 阳性切缘长度标准化报告达成82%共识。
  • 机构内远程报告可行性达成84%共识。
  • 高危病例中>3 mm阳性切缘需完全切除神经血管束达成96%共识。

临床怎么用

  • RARP术中可风险适配使用FCM辅助判断切缘和神经保留决策。
  • 推荐采用en-face成像作为FCM首选技术,并控制报告时间在30分钟内。
  • 高危病例中>3 mm阳性切缘应考虑完全切除神经血管束。
  • 建议对图像解读进行正式认证,并标准化报告阳性切缘长度。
  • 支持机构内远程报告FCM结果。

局限性

  • 证据仍有限且存在知识空白。
  • 共识仅55%条目达成一致,部分领域未形成统一意见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Positive surgical margins (PSMs) after robot-assisted radical prostatectomy (RARP) increase the risk of prostate cancer recurrence, often requiring salvage treatments that may compromise functional recovery. Intraoperative frozen section can detect PSM but is not feasible as a routine approach in most settings. Ex vivo fluorescence confocal microscopy (FCM) provides a rapid, real-time alternative, though evidence remains limited and knowledge gaps persist. This international Delphi consensus aimed to define expert recommendations on the clinical application of and workflow and research priorities for the safe integration of FCM during RARP. MATERIAL AND METHODS: A modified Delphi process was conducted following the RAND/UCLA Appropriateness Method and reported according to the ACCORD checklist. In total, 32 international experts in urology and pathology participated in a hybrid consensus meeting after structured literature review and preparatory online sessions. Forty-four evidence-based multiple-choice items across patient selection, image acquisition, and surgical management domains were developed and anonymously voted on via a secure online platform. Consensus was predefined as ≥80% agreement among respondents. RESULTS: Consensus was achieved for 24 of 44 items (55%). Key agreements included a risk-adapted use of FCM (97%), its role as an adjunct to magnetic resonance imaging for nerve-sparing decisions (87%), adoption of en-face imaging as the preferred FCM technique (82%), and a maximum reporting time of 30 min (85%). The panel endorsed formal certification for image interpretation (83%), standardized reporting of positive margin length (82%), and feasibility of remote intra-institutional reporting (84%). Larger (>3 mm) PSM in high-risk cases warranted complete neurovascular bundle resection (96%). CONCLUSIONS: This consensus provides a structured framework for the intraoperative use of FCM during RARP, defining its indications, workflow standards, and training requirements. Future multicentre studies are needed to assess its oncological and functional impact and to establish standardized implementation pathways.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Beatrici E, de Angelis M, Almeida-Magana R, et al. Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy. BJU Int. 2026. PMID: 42267679. doi:10.1111/bju.70353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。